𝔖 Bobbio Scriptorium

✦ LIBER ✦

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

✍ Scribed by Roger Chou; Rongwei Fu; Laurie Hoyt Huffman; P Todd Korthuis

Book ID: 117300145
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 138 KB
Volume: 368
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(06)69638-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone mineral density changes in protease

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial

✍ AB Hansen; N Obel; H Nielsen; C Pedersen; J Gerstoft 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

A comparison of three highly active anti

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

✍ Rodger D MacArthur; Richard M Novak; Grace Peng; Li Chen; Ying Xiang; Katherine 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 154 KB

First-line antiretroviral therapy with a

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 276 KB

Effects of nucleoside reverse transcript

Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients

✍ A Hill; W Sawyer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB